No evidence that protein truncating variants in <i>BRIP1</i> are associated with breast cancer risk: implications for gene panel testingDouglas F. Easton, Montserrat García‐Closas, Brennan Decker et al.|Journal of Medical Genetics|2016Cited by 104
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort StudyMd. Ismail Hosen, Florence Le Calvez‐Kelm, Paul Brennan et al.|EBioMedicine|2020Cited by 84
Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping AssayLuisa Galati, Tarik Gheit, Jean‐Damien Combes et al.|Microbiology Spectrum|2022Cited by 28